Chlormethine Hydrochloride is Not Inferior to Tacrolimus in Treating Steroid-Resistant Nephrotic Syndrome

Conclusion: The non-inferior efficacy of CHL treatment on the SRNS patients with FSGS or MN compared to TAC treatment, which highlighted CHL can be considered to be alternative treatment for SRNS patients in the clinical setting.Kidney Blood Press Res 2018;43:68 –79
Source: Kidney and Blood Pressure Research - Category: Urology & Nephrology Source Type: research